Kiss E - Search Results

1

The role of NPY in the mediation of orexin-induced hypothermia.

Jászberényi M, Bujdosó E, Kiss E, Pataki I, Telegdy G. Jászberényi M, et al. Among authors: kiss e. Regul Pept. 2002 Mar 15;104(1-3):55-9. doi: 10.1016/s0167-0115(01)00339-1. Regul Pept. 2002. PMID: 11830277

2

Interleukin-1β (187-207)-induced hyperthermia is inhibited by interleukin-1β (193-195) in rats.

Palotai M, Kiss E, Bagosi Z, Jászberényi M, Tóth G, Váradi G, Telegdy G. Palotai M, et al. Among authors: kiss e. Neurochem Res. 2014 Feb;39(2):254-8. doi: 10.1007/s11064-013-1215-9. Epub 2013 Dec 13. Neurochem Res. 2014. PMID: 24338284

3

EGFR Protein Expression of KRAS Wild-Type Colorectal Cancer: Predictive Value of the Sidedness for Efficacy of Anti-EGFR Therapy.

Uhlyarik A, Piurko V, Vizkeleti L, Pápai Z, Rásó E, Lahm E, Kiss E, Sikter M, Vachaja J, Kenessey I, Tímár J. Uhlyarik A, et al. Among authors: kiss e. Pathol Oncol Res. 2020 Jul;26(3):1429-1434. doi: 10.1007/s12253-018-00572-2. Epub 2019 Jan 5. Pathol Oncol Res. 2020. PMID: 30612313 Free article.

4

EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy.

Uhlyarik A, Piurko V, Papai Z, Raso E, Lahm E, Kiss E, Sikter M, Vachaja J, Kenessey I, Timar J. Uhlyarik A, et al. Among authors: kiss e. Cancers (Basel). 2020 Mar 6;12(3):614. doi: 10.3390/cancers12030614. Cancers (Basel). 2020. PMID: 32155907 Free PMC article.

5

[EGFR protein is a negative prognostic and predictive factor in wild-type RAS colorectal cancer].

Uhlyarik A, Piurkó V, Pápai Z, Rásó E, Lahm E, Kiss E, Sikter M, Vachaja J, Vízkeleti L, Kenessey I, Tímár J. Uhlyarik A, et al. Among authors: kiss e. Magy Onkol. 2021 Jun 3;65(2):121-127. Epub 2021 May 16. Magy Onkol. 2021. PMID: 34081760 Free article. Hungarian.

6

[Our experience with targeted therapy in glioblastoma multiforme].

Kiss E, Lahm E, Vachaja J, Nagy P, Bazsó P, Fekete Z, Takácsi-Nagy Z, Pápai Z. Kiss E, et al. Magy Onkol. 2013 Dec;57(4):264-8. Epub 2013 Nov 1. Magy Onkol. 2013. PMID: 24353992 Free article. Hungarian.

7

Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer.

Küronya Z, Szőnyi MD, Nagyiványi K, Gyergyay F, Géczi L, Budai B, Martin T, Ladányi A, Kiss E, Biró K. Küronya Z, et al. Among authors: kiss e. Pathol Oncol Res. 2020 Oct;26(4):2475-2481. doi: 10.1007/s12253-020-00853-9. Epub 2020 Jun 22. Pathol Oncol Res. 2020. PMID: 32572819 Free PMC article.

8

Tumoragnosztikus célzott terápia – tropomiozin-receptor-tirozinkináz gátlása a gyakorlatban.

Kiss E, Pápai Z. Kiss E, et al. Magy Onkol. 2022 Mar 28;66(1):29-33. Epub 2022 Mar 3. Magy Onkol. 2022. PMID: 35343972 Free article. Hungarian.

9

[Novel targeted therapeutic option in oncology: tropomyosin receptor tyrosine kinase inhibitors].

Kiss E, Pápai Z. Kiss E, et al. Orv Hetil. 2021 Aug 22;162(34):1362-1369. doi: 10.1556/650.2021.32183. Orv Hetil. 2021. PMID: 34428172 Hungarian.

10

[Using cannabis in oncology: facts and myths].

Küronya Z, Martin T, Kiss E, Szőnyi M, Bíró K. Küronya Z, et al. Among authors: kiss e. Orv Hetil. 2020 Jun;161(25):1035-1041. doi: 10.1556/650.2020.31733. Orv Hetil. 2020. PMID: 32516121 Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

732 results

Search Page

Filters